SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000014272-17-000052
Filing Date
2017-02-23
Accepted
2017-02-23 19:26:32
Documents
2
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_148789597861408.html 3  
1 FORM 3 wf-form3_148789597861408.xml 3 2348
2 EXHIBIT 24 - MATTHEW EMMENS POWER OF ATTORNEY ex-24.htm EX-24 1419
  Complete submission text file 0000014272-17-000052.txt   5225
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Issuer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Business Address
Emmens Matthew (Reporting) CIK: 0001298332 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-01136 | Film No.: 17634304